What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?

BMJ. 2002 Mar 16;324(7338):666-8. doi: 10.1136/bmj.324.7338.666.

Authors

Ben Ridwan¹, Ellen Mascini, Netty van Der Reijden, Jan Verhoef, Marc Bonten

Affiliation

¹ Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Division of Hospital Hygiene and Infection Prevention, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands. [email protected]

No abstract available

Publication types

Review

MeSH terms

Cross Infection / epidemiology
Cross Infection / prevention & control*
Disease Outbreaks
Drug Resistance, Microbial
Enterococcus / drug effects*
Humans
Infection Control / economics
Infection Control / methods
Netherlands / epidemiology
Streptococcal Infections / drug therapy*
Streptococcal Infections / epidemiology
Streptococcal Infections / prevention & control
Vancomycin / therapeutic use*

Substances

Vancomycin